PANTHERx Sells to Centene

We represented PANTHERx, a specialty pharmacy specializing in orphan drugs and rare diseases, in its sale to Centene Corporation, a diversified, multi-national healthcare enterprise that provides a portfolio of services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Terms of the transaction were not disclosed.

You Also May Be Interested In:

  • Advise a public university system on compliance with the rules associated with grants and contracts from NIH, NSF, and the Department of Defense

    We advise a public university system on compliance with the rules associated with grants and contracts from NIH, NSF, and...
    Client Type: Nonprofit
  • Representation of Parthenon Capital, a growth-oriented private equity firm, as healthcare regulatory counsel in its investment in RxSense, a high-growth healthcare technology company that utilizes its proprietary technology platform to provide innovative prescription savings solutions to consumers and pharmacy benefits administration and analytics to enterprise customers

    We served as healthcare regulatory counsel to Parthenon Capital, a growth-oriented private equity firm, in its investment in RxSense, a...
    Client Type: Private Company
  • Representation of Lead Capital Partners, a multi-family sponsored private equity firm, in its acquisition of Ladd Dental Group, Inc., a dental service provider with six locations throughout central Indiana

    We represented Lead Capital Partners, a multi-family sponsored private equity firm, in its acquisition of Ladd Dental Group, Inc., a...
    Client Type: Private Company